Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8 + T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing Analyses
Advanced Science · 2024
DOI: 10.1002/advs.202403148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yuting He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, CD8-Positive T-Lymphocytes, Xanthophylls, Disease Models, Animal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leading Talents of Zhongyuan Science and Technology Innovation, Henan Medical Science and Technology Research Plan, Outstanding Foreign Scientist Studio in Henan Province.
Abstract (Originalsprache)
Astaxanthin (ASX) is an oxygen‐containing non‐vitamin A carotenoid pigment. However, the role of ASX in autoimmune hepatitis (AIH) remains unclear. In this study, a mouse model of AIH is established induced by concanavalin A (ConA). Mass cytometry and single‐cell RNA sequencing (scRNA‐seq) are used to analyze the potential role of ASX in regulating the immune microenvironment of AIH. ASX treatment effectively alleviated liver damage induced by ConA and downregulated pro‐inflammatory cytokines production in mice. Mass cytometry and scRNA‐seq analyses revealed a significant increase in the number of CD8 + T cells following ASX treatment. Functional markers of CD8 + T cells, such as CD69, MHC II, and PD‐1, are significantly downregulated. Additionally, specific CD8 + T cell subclusters (subclusters 4, 13, 24, and 27) are identified, each displaying distinct changes in marker gene expression after ASX treatment. This finding suggests a modulation of CD8 + T cell function by ASX. Finally, the key transcription factors for four subclusters of CD8 + T cells are predicted and constructed a cell‐to‐cell communication network based on receptor‐ligand interactions probability. In conclusion, ASX holds the potential to ameliorate liver damage by regulating the number and function of CD8 + T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- Key Laboratory of Hepatobiliary and Pancreatic Surgery and Digestive Organ Transplantation of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- Open and Key Laboratory of Hepatobiliary & Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities, Zhengzhou, 450052, China.
- Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou, 450052, China.
ORCID-Profile: Yuting He
Förderung
- Leading Talents of Zhongyuan Science and Technology Innovation
- Henan Medical Science and Technology Research Plan
- Outstanding Foreign Scientist Studio in Henan Province
- Science and technology innovation team in Henan Higher Education Institutions
Zitieren
APA
He, Y., Ding, M., Zhang, J., Huang, C., Shi, J., Wang, Y., Tao, R., Wu, Z., & Guo, W. (2024). Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8 + T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing Analyses. Advanced Science. https://doi.org/10.1002/advs.202403148
Vancouver
He Y, Ding M, Zhang J, Huang C, Shi J, Wang Y, et al. Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8 + T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing Analyses. Advanced Science. 2024. doi:10.1002/advs.202403148
BibTeX
@article{He2024,
author = {He, Yuting and Ding, Mingjie and Zhang, Jiakai and Huang, Changjun and Shi, Jihua and Wang, Yun and Tao, Ruolin and Wu, Zeyu and Guo, Wenzhi},
title = {Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8 + T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing Analyses},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202403148}
}
EUVIMED